Experts warn of untreatable TB risk

Disease experts called Sunday for decisive leadership and more research funding to fend off the "very real" risk of an untreatable strain of tuberculosis (TB) emerging as more and more people develop resistance to existing drugs.

In a series of papers in the Lancet medical journal to mark World TB Day on Sunday, they warned that health systems risked being overwhelmed by increasing numbers of drug-resistant TB patients.

Already, more than 30 percent of newly-diagnosed patients in parts of eastern Europe and central Asia have multi-drug resistant (MDR) TB, a form of the disease which does not respond to the two most potent drugs—isoniazid and .

There were believed to be about 630,000 MDR cases out of some 12 million TB cases in 2011.

Extensively drug resistant (XDR) TB, thus far reported in 84 countries, does not respond to an even wider range of drugs.

"The widespread emergence of XDR tuberculosis could lead to virtually untreatable tuberculosis," wrote the authors of one study, led by Alimuddin Zumla, director of the Centre for Infectious Diseases and International Health at University College London Medical School.

"With ease of international travel and increased rates of MDR tuberculosis... the threat and range of the spread of untreatable tuberculosis is very real," they said.

TB was declared a global health emergency by the (WHO) 20 years ago, but remains a leading cause of death by an infectious disease.

On its website, the UN agency says at least $1.6 billion (1.2 billion euros) is needed annually to prevent the spread of the disease.

For their part, the study authors urged "a radical change in political and scientific thinking".

"The global economic crisis and reduced investments in health services threaten national tuberculosis programmes and the gains made in global tuberculosis control," they wrote.

"The world needs to acknowledge the serious threat of drug-resistant tuberculosis before it overwhelms health systems."

Most needed are new drugs and better, quicker diagnostic tools.

In 2011, 8.7 million people fell ill with TB and 1.4 million died, said the WHO.

Over 95 percent of TB deaths occur in low- and middle-income countries, and it is among the top three causes of death for women aged 15 to 44.

In 2010, there were about 10 million orphans who had lost their parents to TB.

It is also a leading killer of people with HIV.

The death rate did drop by 41 percent between 1990 and 2011, according to the WHO, which says the world is on course to achieve the Millennium Development Goal of reversing the spread of TB by 2015.

"We have gained a lot of ground in TB, but it can easily be lost if we do not act now," WHO director general Margaret Chan said in a statement.

An airborne disease of the lungs, is usually treatable with a six-month course of antibiotics.

It is spread from person to person through the air and usually affects the lungs, but it can also affect other parts of the body such as the brain and kidneys.

Resistance to TB drugs develops when treatment fails to kill the bacteria that causes it—either because the patient fails to follow their prescribed dosages or the drug doesn't work.

It can also be contracted through rare forms of the disease that are directly transmissible from person to person.

MDR TB in the United States can cost as much as $250,000 (200,000 euros) per patient to treat.

XDR TB requires about two years of treatment with even more expensive drugs that often cause side-effects and offer no guarantee of a cure.

add to favorites email to friend print save as pdf

Related Stories

WHO: Money, drugs needed to rein in new TB strains

Mar 23, 2009

(AP) -- More money and better science are urgently needed to rein in new strains of tuberculosis that are tough or nearly impossible to treat, the WHO announced Monday in China, where the disease has long been a leading ...

Drug-resistant tuberculosis rife in China

Dec 11, 2008

Levels of drug-resistant tuberculosis (TB) in China are nearly twice the global average. Nationwide research published in the open access journal BMC Infectious Diseases has shown that almost 10% of Chinese TB cases are re ...

Recommended for you

Ebola vaccine promising in first human trials

2 hours ago

Researchers say they are one step closer to developing a viable Ebola vaccine, with a Phase 1 trial showing promising results, but it will still be months at least before it could be used in the field.

At one month, US Ebola monitors finding no cases

4 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

EU calls for 5,000 doctors to fight Ebola

5 hours ago

The European Commission called for 5,000 doctors to be sent from EU states to combat west Africa's Ebola epidemic, a European source with knowledge of the matter said on Wednesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.